Control_0d_vs_Treatment_180d

Profile details

Identifier: MTBLS5335_0002_00000003
Linked study: MTBLS5335 — Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
Comparison: Control_0d vs Treatment_180d
Group A: Baseline control group at day 0. Provides baseline data for comparison with samples collected at later time points.
Group B: Treatment group at day 180. Captures the long-term effects of the intervention for comparison with baseline data.
Total features tested: 1739
Significant features: 417
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
XNVIXRMFBUDCLP-UHFFFAOYSA-N	oxacyclohenicosan-2-one	up	1.176e+11	0.0109
DSOWUEHXZJUNID-WHXUGTBJSA-N	LysoPE 16:1(9Z)/0:0	up	32.09	4.99e-07
OOBIPIXEFDBKDI-HWKANZROSA-N	—	up	10.03	3.19e-08
DDSIZVYRTNDIJL-UHFFFAOYSA-N	N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propanamide	up	8.087	6.92e-09
NDDJIMSGSZNACM-QWRGUYRKSA-N	N-(3S-hydroxydecanoyl)-L-serine	up	7.659	1.28e-08
IRRHFODGOMSPEE-IXCDTRSDSA-N	(3S,8S,9S,10R,13S,14S,16R,17R)-10,13-dimethyl-17-[(1S)-1-[(2S,5S)-5-methylpiperidin-2-yl]ethyl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16-diol	up	98.08	0.00107
AWMHMGFGCLBSAY-UHFFFAOYSA-N	2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2,3-dihydrouro[3,2-g]chromen-2-yl]propan-2-yl acetate	up	4.531	1.12e-09
BBOWBNGUEWHNQZ-KTKRTIGZSA-N	(10Z)-nonadec-10-enoic acid	up	255	0.00394
FBJQEBRMDXPWNX-SMGIPPFUSA-N	Manninotriose	up	314.8	0.00512
RPXHXZNGZBHSMJ-GOSISDBHSA-N	1-tetradecanoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion	up	15.34	1.98e-05